微创手术治疗(MISTs)的并发症发生率:现状如何?文献系统回顾。

IF 5.1 2区 医学 Q1 ONCOLOGY
Luca Lambertini, Alessandro Sandulli, Simone Coco, Daniele Paganelli, Anna Cadenar, Paolo Dell'Oglio, Stefano Puliatti, Fabrizio Di Maida, Antonio Andrea Grosso, Daniele Amparore, Riccardo Bertolo, Riccardo Campi, Riccardo Lombardo, Matteo Ferro, Bernardo Rocco, Gianni Vittori, Alessandro Antonelli, Cosimo De Nunzio, Andrea Minervini, Andrea Mari
{"title":"微创手术治疗(MISTs)的并发症发生率:现状如何?文献系统回顾。","authors":"Luca Lambertini, Alessandro Sandulli, Simone Coco, Daniele Paganelli, Anna Cadenar, Paolo Dell'Oglio, Stefano Puliatti, Fabrizio Di Maida, Antonio Andrea Grosso, Daniele Amparore, Riccardo Bertolo, Riccardo Campi, Riccardo Lombardo, Matteo Ferro, Bernardo Rocco, Gianni Vittori, Alessandro Antonelli, Cosimo De Nunzio, Andrea Minervini, Andrea Mari","doi":"10.1038/s41391-024-00900-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Over the past decade, the range of surgical options to benign prostatic obstruction (BPO) has expanded significantly with the advent of minimally invasive surgical therapies (MISTs). Nevertheless, the available evidence in the field is heterogeneous. Efficacy and safety thresholds are yet to be determined.</p><p><strong>Objective: </strong>To evaluate perioperative and long-term complications after MISTs - including Aquablation, steam injection (Rezūm), Transperineal laser ablation of the prostate (TPLA), implantation of a prostatic urethral lift (PUL) and temporary implantable nitinol device (iTIND) - in patients with lower urinary tract symptoms due to BPO.</p><p><strong>Evidence acquisition: </strong>A systematic literature search was conducted in January 2024 using Medline (via PubMed), Embase (via Ovid), Scopus, and Web of Science. The search strategy used PICO criteria (Patients, Interventions, Comparisons, Outcomes) [1], focusing specifically on patients with BPH-associated LUTS who underwent MIST or other comparative treatments, aiming to assess both perioperative and long-term safety outcomes. Article selection was conducted in accordance with the PRISMA guidelines. The risk of bias and the quality of the articles included were assessed. A dedicated data extraction form was used to collect the data of interest.</p><p><strong>Evidence synthesis: </strong>The initial electronic search identified 3660 records, of which 24 ultimately met the inclusion criteria and were included in the analysis. Overall, Aquablation was associated with a higher major complications rate of 14% (IQR 6-22), particularly in the case of patients with prostates <70 ml. PUL showed a higher early postoperative acute urinary retention rate (10.9%, IQR 9.2-12.3%), while 1.4% of patients treated with iTIND experienced major perioperative complications. Urinary tract infections were mostly reported in series assessing TPLA and Rezūm.</p><p><strong>Conclusions: </strong>The adoption of MISTs for LUTS due to BPH is associated with a varied spectrum of perioperative and long-term complications. Our findings showed an acceptable safety profile with specific complications dependent on the type of MIST performed, highlighting the importance of individualized patient selection and procedure-specific considerations.</p>","PeriodicalId":20727,"journal":{"name":"Prostate Cancer and Prostatic Diseases","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature.\",\"authors\":\"Luca Lambertini, Alessandro Sandulli, Simone Coco, Daniele Paganelli, Anna Cadenar, Paolo Dell'Oglio, Stefano Puliatti, Fabrizio Di Maida, Antonio Andrea Grosso, Daniele Amparore, Riccardo Bertolo, Riccardo Campi, Riccardo Lombardo, Matteo Ferro, Bernardo Rocco, Gianni Vittori, Alessandro Antonelli, Cosimo De Nunzio, Andrea Minervini, Andrea Mari\",\"doi\":\"10.1038/s41391-024-00900-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Over the past decade, the range of surgical options to benign prostatic obstruction (BPO) has expanded significantly with the advent of minimally invasive surgical therapies (MISTs). Nevertheless, the available evidence in the field is heterogeneous. Efficacy and safety thresholds are yet to be determined.</p><p><strong>Objective: </strong>To evaluate perioperative and long-term complications after MISTs - including Aquablation, steam injection (Rezūm), Transperineal laser ablation of the prostate (TPLA), implantation of a prostatic urethral lift (PUL) and temporary implantable nitinol device (iTIND) - in patients with lower urinary tract symptoms due to BPO.</p><p><strong>Evidence acquisition: </strong>A systematic literature search was conducted in January 2024 using Medline (via PubMed), Embase (via Ovid), Scopus, and Web of Science. The search strategy used PICO criteria (Patients, Interventions, Comparisons, Outcomes) [1], focusing specifically on patients with BPH-associated LUTS who underwent MIST or other comparative treatments, aiming to assess both perioperative and long-term safety outcomes. Article selection was conducted in accordance with the PRISMA guidelines. The risk of bias and the quality of the articles included were assessed. A dedicated data extraction form was used to collect the data of interest.</p><p><strong>Evidence synthesis: </strong>The initial electronic search identified 3660 records, of which 24 ultimately met the inclusion criteria and were included in the analysis. Overall, Aquablation was associated with a higher major complications rate of 14% (IQR 6-22), particularly in the case of patients with prostates <70 ml. PUL showed a higher early postoperative acute urinary retention rate (10.9%, IQR 9.2-12.3%), while 1.4% of patients treated with iTIND experienced major perioperative complications. Urinary tract infections were mostly reported in series assessing TPLA and Rezūm.</p><p><strong>Conclusions: </strong>The adoption of MISTs for LUTS due to BPH is associated with a varied spectrum of perioperative and long-term complications. Our findings showed an acceptable safety profile with specific complications dependent on the type of MIST performed, highlighting the importance of individualized patient selection and procedure-specific considerations.</p>\",\"PeriodicalId\":20727,\"journal\":{\"name\":\"Prostate Cancer and Prostatic Diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2024-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prostate Cancer and Prostatic Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41391-024-00900-5\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate Cancer and Prostatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41391-024-00900-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:过去十年间,随着微创手术疗法(MIST)的出现,良性前列腺梗阻(BPO)的手术选择范围大幅扩大。然而,该领域的现有证据并不一致。疗效和安全性阈值尚待确定:目的:评估因BPO引起下尿路症状的患者接受MIST(包括水消融术、蒸汽注射(Rezūm)、经会阴前列腺激光消融术(TPLA)、前列腺尿道提升器植入术(PUL)和临时植入式镍钛诺装置(iTIND))治疗后的围手术期和长期并发症:2024 年 1 月,通过 Medline(通过 PubMed)、Embase(通过 Ovid)、Scopus 和 Web of Science 进行了系统性文献检索。检索策略采用 PICO 标准(患者、干预、比较、结果)[1],特别关注接受 MIST 或其他比较治疗的良性前列腺增生相关 LUTS 患者,旨在评估围手术期和长期安全性结果。文章的选择符合 PRISMA 指南。对纳入文章的偏倚风险和质量进行了评估。使用专用数据提取表收集相关数据:最初的电子检索发现了 3660 条记录,其中 24 条最终符合纳入标准并纳入分析。总体而言,水消融术的主要并发症发生率较高,为14%(IQR 6-22),尤其是前列腺患者:采用 MIST 治疗良性前列腺增生引起的尿失禁与各种围手术期和长期并发症有关。我们的研究结果表明,MIST 的安全性是可以接受的,具体并发症取决于所实施的 MIST 类型,这突出了个性化患者选择和特定手术注意事项的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature.

Background: Over the past decade, the range of surgical options to benign prostatic obstruction (BPO) has expanded significantly with the advent of minimally invasive surgical therapies (MISTs). Nevertheless, the available evidence in the field is heterogeneous. Efficacy and safety thresholds are yet to be determined.

Objective: To evaluate perioperative and long-term complications after MISTs - including Aquablation, steam injection (Rezūm), Transperineal laser ablation of the prostate (TPLA), implantation of a prostatic urethral lift (PUL) and temporary implantable nitinol device (iTIND) - in patients with lower urinary tract symptoms due to BPO.

Evidence acquisition: A systematic literature search was conducted in January 2024 using Medline (via PubMed), Embase (via Ovid), Scopus, and Web of Science. The search strategy used PICO criteria (Patients, Interventions, Comparisons, Outcomes) [1], focusing specifically on patients with BPH-associated LUTS who underwent MIST or other comparative treatments, aiming to assess both perioperative and long-term safety outcomes. Article selection was conducted in accordance with the PRISMA guidelines. The risk of bias and the quality of the articles included were assessed. A dedicated data extraction form was used to collect the data of interest.

Evidence synthesis: The initial electronic search identified 3660 records, of which 24 ultimately met the inclusion criteria and were included in the analysis. Overall, Aquablation was associated with a higher major complications rate of 14% (IQR 6-22), particularly in the case of patients with prostates <70 ml. PUL showed a higher early postoperative acute urinary retention rate (10.9%, IQR 9.2-12.3%), while 1.4% of patients treated with iTIND experienced major perioperative complications. Urinary tract infections were mostly reported in series assessing TPLA and Rezūm.

Conclusions: The adoption of MISTs for LUTS due to BPH is associated with a varied spectrum of perioperative and long-term complications. Our findings showed an acceptable safety profile with specific complications dependent on the type of MIST performed, highlighting the importance of individualized patient selection and procedure-specific considerations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases 医学-泌尿学与肾脏学
CiteScore
10.00
自引率
6.20%
发文量
142
审稿时长
6-12 weeks
期刊介绍: Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management. Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis. Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信